1 Day
Source:
The Fiscal Times
The Fiscal Times
Ready to play
Ready to play
President Trump announced plans to impose tariffs of up to 100% on imported generic drugs starting in 2028, aiming to encourage domestic manufacturing. Experts are skeptical whether these tariffs alone will effectively prompt companies to reshore production, citing high costs and infrastructure requirements. The move could impact drug prices slightly and risk supply shortages if manufacturers decide to exit the U.S. market due to added financial pressures.
Notice: This Is an AI-Generated Summary
Comments (0)